Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Tomasz Guszczyn; Monika Kulesza; Aleksandra Kicman; Joanna Motyka; Sławomir Ławicki

doi:10.12659/MSM.941523

18 December 2023 : Clinical Research

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Tomasz Guszczyn

^1ABDEF*, Monika Kulesza

^2BCDEF, Aleksandra Kicman

^3CF, Joanna Motyka

^2CF, Sławomir Ławicki

^2AEG

DOI: 10.12659/MSM.941523

Med Sci Monit 2023; 29:e941523

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Comparison of the knee pain VAS (The Visual Analogue Scale) and function scales (Lysholm, Tegner, KOOS) scores according to the conservative treatment used.

Back to the Article

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Your Privacy